OSEO awards Cytheris EUR1.5m
OSEO, France's national agency for industrial innovation, has awarded Cytheris a EUR1.5m no interest loan. The company is a clinical stage biopharmaceutical company focusing on hepatitis-C.
The funding will be used to continue the development of Cytheris' lead product Interleukin-7, a growth factor for immune T-cell recovery.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








